Skip to Main Content

Paper Details

Low-dose IL-2 shapes a tolerogenic gut microbiota that improves autoimmunity and gut inflammation.
JCI Insight
7
2022
16S ribosomal RNA, IL-2, IL-2LD, L-arginine, Treg, Tregs, amino acids, autoimmune and inflammatory diseases, autoimmunity, cardiometabolic, neurological, and autoimmune diseases, colitis, diabetes, gut inflammation, humans, inflammatory bowel diseases, mice, short-chain fatty acids, sodium, sulfate
Author NameAffiliation
Nicolas TchitchekSorbonne Universite, INSERM
Francesco Strozzi
Francesco Strozzi
Harry SokolMicalis Institute, Institut National de la Recherche Agronomique (INRA)
Harry SokolSorbonne Universite, Ecole Normale Superieure, CNRS, INSERM
Harry Sokol
  • 1 - 6

Datasets

Release 1.2